Watch breaking news videos and read news updates about Drug Companies on FOXBusiness.com.
LATEST VIDEOS
Where is the Best Value in the Markets Now?
11/20/2009|FOX Business Morning
BGC Partners' David Buik on the best sectors for investors right now.
Ron Paul on Rolling Back Big Government
11/04/2009|America's Nightly Scoreboard
Rep. Ron Paul on what successful Republican elections mean for government.
Did Dems' Arrogance Cost Them Elections?
11/04/2009|Happy Hour on FOX Business
Professor Peter Morici on why New Jersey and Virginia went to the GOP.
Toymaker Hasbro reported higher third-quarter profits but Gannett showed a big decline in ad revenue.
What Big Pharma Gains From Health Reform
10/19/2009|FOX Business
Leerink Swann's John Sullivan on health reform's impact on the pharmaceutical industry.
Ex-CBO Director on Health-Care Costs
10/12/2009|FOX Business
Fmr. Congressional Budget Office Director Douglas Holtz-Eakin on health-care reform's impact on the national debt.
Red Ink Watch: Selling the Health Plan
10/09/2009|FOX Business
Democratic Strategist Tara Dowdell argues the middle class will not pay for health reform.
Fmr. Medtronic CEO on Health Care
10/06/2009|Closing Bell
Former Medtronic CEO Bill George says taxing innovation is a terrible idea.
How Will Health-Care Reform Impact Pharma?
09/25/2009|FOX Business
Morningstar Equity Analyst Damien Conover on health-care reform's impact on pharmaceutical companies.
LATEST STORIES
| FOXBusiness| Markets
taxing insurers on high-value or so-called "Cadillac" plans. Or levying new taxes on insurance companies and drug companies ...The fear there being those guys will only pass those increases along to customers. So customers balk
Story|11/18/2009
Buried in the Times « John Stossel
Other Stories
however unfair this may or may not be. October 30, 2009 at 8:56 pm LAD I suspect the R&D budgets of private drug companies more closely reflect (i) the likelihood of developing an effective and safe drug, (ii) the number of potential
Blog|10/30/2009
FOXBusiness| Markets
29 billion pounds a year ago. Glaxo is expected to reap continued benefits from the H1N1 vaccine as only a few drug companies were able to bring mass quantities to market in time for flu season, and the company has already reported orders
Story|10/28/2009
Is Buying Big Pharma The Perfect Health Care Hedge? « The Brian Sullivan Blog
The Brian Sullivan Blog
for years on end and which drive profits in the industry. A health care bill may change that for the benefit of the drug companies . A plan that requires all Americans to have some form of health insurance will likely be a bonanza for the pharmaceutical
Blog|10/13/2009
What Congress Will Find in Health Insurer Pay « Emac's Stock Watch
Emac's Stock Watch
committee (Health,and Human Services) chair vote on the Health Care Reform for RX's in 2000 when he voted to let the Drug Companies sell drugs to the government with absolutely no competitive pricing (in other words whatever the Pharmaceuticals
Blog|10/08/2009
12 Takeaways & Comments On “Baucus-care” Bill « The Brian Sullivan Blog
The Brian Sullivan Blog
covered on plan formularies when beneficiaries enter the coverage gap. Comment: Good for Medicare recipients, bad for drug companies . Few but the companies and their investors will care, but we must remember future drug development is based on past
Blog|09/15/2009
What the President Ignored « Emac's Stock Watch
Emac's Stock Watch
relations than for true change." And watch for any indication that the Administration’s cloakroom deal with drug companies , who vowed to deliver up to $80 bn in savings, was made in return for the costly promise that Medicare won’t
Blog|09/10/2009
Obama Takes Health-Reform Case to Capitol Hill
| FOXBusiness| Markets
have been supported by an unprecedented coalition of doctors and nurses; hospitals, seniors’ groups and even drug companies -- many of whom opposed reform in the past. And there is agreement in this chamber on about 80% of what needs to
Story|09/09/2009
Madoff Case May Bring New Whistleblower Bounties
Reuters| Markets
out only about $150,000 in the past few years for tips on insider trading. Meanwhile, tipsters on wrongdoing by drug companies reap estimated rewards of more than $250 million a year from the agency. Former Pfizer sales rep John Kopchinski
Story|09/04/2009
Cavuto: Lawmakers Ganging Up on Insurance Firms
| FOXBusiness| Markets
s proposed health-care reform. They're not being good boys. Not like those other once-greedy SOBs -- the drug companies -- who suddenly are being good boys, and suddenly "aren't" greedy SOB's. Amazing. But not surprising. Amazing
Story|08/19/2009